loadpatents
name:-0.049412965774536
name:-0.028956174850464
name:-0.0097091197967529
LU; Kun Ping Patent Filings

LU; Kun Ping

Patent Applications and Registrations

Patent applications and USPTO patent grants for LU; Kun Ping.The latest application filed is for "modulators of pin1 activity and uses thereof".

Company Profile
11.28.43
  • LU; Kun Ping - Newton MA
  • Lu; Kun Ping - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modulators Of Pin1 Activity And Uses Thereof
App 20210332024 - LONDON; Nir ;   et al.
2021-10-28
Methods and compositions for the inhibition of PIN1
Grant 11,129,835 - Lu , et al. September 28, 2
2021-09-28
Peptidomimetic Inhibitors Of The Peptidyl-prolyl Cis/trans Isomerase (pin1)
App 20210238225 - GRAY; Nathanael ;   et al.
2021-08-05
Arsenic trioxide for treatment of PIN1-associated disorders
Grant 10,980,835 - Lu , et al. April 20, 2
2021-04-20
Methods And Compositions For The Generation And Use Of Conformation-specific Antibodies
App 20200291134 - LU; Kun Ping ;   et al.
2020-09-17
Methods And Compositions For The Inhibition Of Pin1
App 20200093832 - LU; Kun Ping ;   et al.
2020-03-26
Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions
Grant 10,548,864 - Lu , et al. Fe
2020-02-04
Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
Grant 10,487,114 - Lu , et al. Nov
2019-11-26
Methods and compositions for the treatment of proliferative disorders
Grant 10,485,780 - Lu , et al. Nov
2019-11-26
Methods and compositions for the inhibition of Pin1
Grant 10,413,548 - Lu , et al. Sept
2019-09-17
Biomarkers for Pin1-associated disorders
Grant 10,351,914 - Lu , et al. July 16, 2
2019-07-16
Methods and compositions for the treatment of proliferative disorders
Grant 10,265,288 - Lu , et al.
2019-04-23
Arsenic Trioxide For Treatment Of Pin1-associated Disorders
App 20180153934 - LU; Kun Ping ;   et al.
2018-06-07
ATRA for modulating Pin1 activity and stability
Grant 9,968,579 - Lu , et al. May 15, 2
2018-05-15
Methods And Compositions For The Generation And Use Of Conformation-specific Antibodies
App 20180072814 - LU; Kun Ping ;   et al.
2018-03-15
Enhanced Atra-related Compounds For The Treatment Of Proliferative Diseases, Autoimmune Diseases, And Addiction Conditions
App 20180064666 - LU; Kun Ping ;   et al.
2018-03-08
Methods And Compositions For The Inhibition Of Pin1
App 20170304310 - LU; Kun Ping ;   et al.
2017-10-26
Methods and compositions for the generation and use of conformation-specific antibodies
Grant 9,796,784 - Lu , et al. October 24, 2
2017-10-24
Methods and compositions for the inhibition of Pin1
Grant 9,730,941 - Lu , et al. August 15, 2
2017-08-15
Biomarkers For Pin1-associated Disorders
App 20170204466 - LU; Kun Ping ;   et al.
2017-07-20
Atra For Modulating Pin1 Activity And Stability
App 20170202799 - LU; Kun Ping ;   et al.
2017-07-20
Methods and compositions for the generation and use of conformation-specific antibodies
Grant 9,688,747 - Lu , et al. June 27, 2
2017-06-27
Enhanced Atra-related Compounds Derived From Structure-activity Relationships And Modeling For Inhibiting Pin1
App 20170112792 - LU; Kun Ping ;   et al.
2017-04-27
Methods for the treatment of immune disorders
Grant 9,439,884 - Lu , et al. September 13, 2
2016-09-13
Methods And Compositions For The Generation And Use Of Conformation-specific Antibodies
App 20160031977 - LU; Kun Ping ;   et al.
2016-02-04
Methods And Compositions For The Inhibition Of Pin1
App 20150133442 - Lu; Kun Ping ;   et al.
2015-05-14
Methods And Compositions For The Treatment Of Proliferative Disorders
App 20150044278 - LU; Kun Ping ;   et al.
2015-02-12
Methods And Compositions For The Generation And Use Of Conformation-specific Antibodies
App 20150038683 - LU; Kun Ping ;   et al.
2015-02-05
Methods And Compositions For The Generation And Use Of Conformation-specific Antibodies
App 20140242100 - Lu; Kun Ping ;   et al.
2014-08-28
Methods And Compositions For The Treatment Of Immune Disorders
App 20140219957 - Lu; Kun Ping ;   et al.
2014-08-07
Methods and compositions for the generation and use of conformation-specific antibodies
Grant 8,771,693 - Lu , et al. July 8, 2
2014-07-08
Methods And Compositions For The Treatment Of Proliferative Disorders
App 20140086909 - Lu; Kun Ping ;   et al.
2014-03-27
Methods And Compositions For The Generation And Use Of Conformation-specific Antibodies
App 20130028900 - Lu; Kun Ping ;   et al.
2013-01-31
Pin1-modulating compounds and methods of use thereof
Grant 8,258,099 - Lu , et al. September 4, 2
2012-09-04
Pin1 as a marker for abnormal cell growth
Grant 8,129,131 - Lu , et al. March 6, 2
2012-03-06
Pin1 as a marker for abnormal cell growth
App 20090258352 - Lu; Kun Ping ;   et al.
2009-10-15
Pin1-Modulating Compounds and Methods of Use Thereof
App 20080214470 - Lu; Kun Ping ;   et al.
2008-09-04
Alzheimer's Disease Therapeutics Based On Pin-1 Catalyzed Conformational Changes In Phosphorylated Amyloid Precursor Protein
App 20080058276 - LU; Kun Ping ;   et al.
2008-03-06
NIMA interacting proteins
App 20070042467 - Hunter; Tony ;   et al.
2007-02-22
NIMA interacting proteins
Grant 7,164,012 - Hunter , et al. January 16, 2
2007-01-16
NIMA interacting proteins
Grant 7,148,003 - Hunter , et al. December 12, 2
2006-12-12
NIMA interacting proteins
Grant 7,125,955 - Hunter , et al. October 24, 2
2006-10-24
NIMA interacting proteins
Grant 7,125,677 - Hunter , et al. October 24, 2
2006-10-24
Determination of a phosphorylation site in PPIase domain of Pin1 and uses therefor
App 20060074222 - Lu; Kun Ping ;   et al.
2006-04-06
Methods and compositions for regulating protein-protein interactions
App 20050282740 - Lu, Kun Ping ;   et al.
2005-12-22
Use of Pin1 inhibitors for treatment of cancer
App 20050239095 - Lu, Kun Ping ;   et al.
2005-10-27
Pin1 as a marker for abnormal cell growth
App 20050186643 - Lu, Kun Ping ;   et al.
2005-08-25
Novel regulatory mechanisms of NF-kappaB
App 20050147608 - Ryo, Akihide ;   et al.
2005-07-07
NIMA interacting proteins
App 20050049404 - Hunter, Tony ;   et al.
2005-03-03
NIMA interacting proteins
App 20050033032 - Hunter, Tony ;   et al.
2005-02-10
NIMA interacting proteins
App 20050027107 - Hunter, Tony ;   et al.
2005-02-03
Novel telomerase inhibitors and uses therefor
App 20040142357 - Lu, Kun Ping ;   et al.
2004-07-22
Methods of treating neurodegenerative diseases
App 20040123334 - Lu, Kun Ping ;   et al.
2004-06-24
NIMA interacting proteins
App 20040101896 - Hunter, Tony ;   et al.
2004-05-27
Antibodies to NIMA interacting proteins
Grant 6,596,848 - Hunter , et al. July 22, 2
2003-07-22
Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
App 20030109423 - Lu, Kun Ping ;   et al.
2003-06-12
Methods of inhibiting Pin1-associated states using a fredericamycin a compound
App 20030055072 - Lu, Kun Ping ;   et al.
2003-03-20
Methods and compositions for regulating protein-protein interactions
App 20030049672 - Lu, Kun Ping ;   et al.
2003-03-13
Methods and compositions for regulating protein-protein interactions
Grant 6,495,376 - Lu , et al. December 17, 2
2002-12-17
Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
Grant 6,462,173 - Lu , et al. October 8, 2
2002-10-08
Pin1 as a marker for abnormal cell growth
App 20020025521 - Lu, Kun Ping ;   et al.
2002-02-28
NIMA interacting proteins
Grant 5,972,697 - Hunter , et al. October 26, 1
1999-10-26
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed